Steve Littlejohn

cropped-SLittlejohn-ColorWeb.jpg

 

 

 

 

Steve Littlejohn  is a 35-year communications and public affairs veteran with more than 20 years of experience in healthcare.  Throughout his career, Steve has helped organizations successfully navigate global challenges and opportunities in areas such as change management, culture change and employee engagement, crisis planning and management, alliance and coalition building, issues and reputation management, government relations and strategic marketing.

Most recently, Steve was Senior Consultant and Vice President, Marketing and Communications for Numerof & Associates, Inc., a healthcare strategy consulting firm.

Earlier, Steve served as Vice President, Communications and Public Affairs, for Mallinckrodt when it was the pharmaceuticals business of medical device manufacturer Covidien.  For this $2 billion business he led the communications, product support, public affairs, community relations, and issues management team.  While at Mallinckrodt, he globalized employee engagement communications, successfully resolved U.S. and E.U. nuclear medicine issues for the company and oversaw new corporate branding before Covidien spun-off Mallinckrodt.

Prior to Mallinckrodt, Steve served as Vice President, Public Affairs, at the pharmacy benefit manager, Express Scripts, where he implemented an award-winning generic drug campaign saving clients millions and led creation of the SOSRx drug safety coalition with the National Consumers League.  He also served as corporate public spokesman, community relations lead, and executive communications support.

Before joining Express Scripts, Steve established the integrated communications agency Kupper Parker as one of the nation’s fastest growing healthcare public relations agencies.  Clients included pharmaceutical, managed care, provider, government, and health information technology organizations.  Earlier, at the global communications firm FleishmanHillard, he built a million dollar healthcare services practice, led the St. Louis health and environment group, and developed a patient safety crisis communications specialty.  Mr. Littlejohn played a key role in the formation of the National Patient Safety Foundation, serving on the inaugural board, and chairing the communications committee.  He currently serves on the foundation’s Board of Advisors.  Previously, he held positions at DuPont, Gulf Oil, and Monsanto.

Steve earned a B.A. in history from Harvard University, an M.A. in history from Cambridge University and an M. B. A. from the University of Pittsburgh.  He is the author of “Competition and Cooperation: New Trends in Corporate Public Issue Identification and Resolution” (California Management Review) and a co-author of “Innovation on Trial: Punitive Damages Versus New Products” (Science).

For more, visit Steve’s LinkedIn page.

Leave a Reply